Pathogenesis of portal hypertensive gastropathy in cirrhotic patients and the application of antacids in treatment / 临床肝胆病杂志
Journal of Clinical Hepatology
;
(12): 2218-2221, 2017.
Article
in Chinese
| WPRIM
| ID: wpr-663304
ABSTRACT
Portal hypertensive gastropathy (PHG) has a high incidence rate in cirrhotic patients,leading to a high risk of upper gastrointestinal bleeding.Gastric mucosal injury is the major pathological change of PHG.There are few studies focusing on the clinical application of antacids in the treatment of PHG in cirrhotic patients and there are still controversies over this issue.This article reviews the influencing factors for PHG,the mechanism of gastric mucosal injury,and the application of antacids.It is pointed out that during the treatment of PHG,besides the reduction in portal venous pressure,the application of antacids such as proton pump inhibitors can improve the cure rate of PHG.Prospective randomized control trials with a large sample size are needed to further demonstrate the clinical effect and safety of antacids in the treatment of PHG in cirrhotic patients.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Controlled clinical trial
/
Etiology study
Language:
Chinese
Journal:
Journal of Clinical Hepatology
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS